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esponsibility of Xi'aAbstract A gas chromatography mass spectrometry (GC–MS) method has been developed and fully
validated for the simultaneous determination of natural borneol (NB) and its metabolite, camphor, in rat
plasma. Following a single liquid–liquid extraction, the analytes were separated using an HP-5MS
capillary column (0.25 mm 30 m 0.25 μm) and analyzed by MS in the selected ion monitoring mode.
Selected ion monitor (m/z) of borneol, camphor and internal standard was 95, 95 and 128, respectively.
Linearity, accuracy, precision and extraction recovery of the analytes were all satisfactory. The method
was successfully applied to pharmacokinetic studies of NB after oral administration to Wistar rats.
& 2014 Xi’an Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Borneol (Fig. 1A), usually used as an important adjuvant in
“Su-Xiao-Jiu-Xin-Wan”, “Su-He-Xiang-Wan”, and “Liu-Shen-Wan”
for preventing and curing cardiovascular and cerebrovascular diseases
[1,2]. It is classiﬁed into natural borneol (NB) and synthetical borneol
(SB). Because SB is much easier to get and cheaper than NB, it has
been widely used in Chinese formulas. But due to its unstable quality
in storage, it can be transformed into camphor and result in higher
reproductive toxicity [3–5]. Camphor is reported to cause seizures,sity. Production and hosting by Elsev
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(Z.-Y. Xie).
n Jiaotong University.respiratory failure, myocarditis and hepatotoxicity; fetuses and infants
are specially susceptible to camphor [6–8]. Therefore, NB is
becoming more and more widely used. However, there are few
reports about its in vivo study, and let alone its metabolite.
Several papers about the pharmacokinetic study of NB have
been reported. These results indicate that camphor is the main
metabolite of NB, too [9–13]. Therefore, it is necessary to study
the pharmacokinetics of camphor after oral administration of NB
and to discuss the conversion ration from NB to camphor in vivo
for the purpose of safety. In this paper, we hereby developed a
systematic gas chromatography mass spectrometry (GC–MS)
method for the simultaneous determination of borneol and
camphor in rat plasma. It was successfully applied to the
pharmacokinetic study of NB in Wistar rats.ier B.V. All rights reserved.
Fig. 1 Structures of borneol (A), camphor (B), and naphthalene (C).
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2.1. Chemicals and reagents
NB reference standard (purity 499.9%) and camphor (purity
499.3%) were purchased from the National Institute for the Control
of Pharmaceutical and Biological Products (Beijing, China). Naphtha-
lene (purity Z98%, internal standard, IS, Fig. 1C) was purchased
from Damao Chemical Reagent Factory (Tianjin, China). NB (99.4%
purity, batch no. 20060800) was purchased from Linke NB Factory
(Jiangxi, China) for animal experiments.
2.2. Apparatus and operating conditions
A Thermo DSQ IITrace GC–MS system (Thermo Scientiﬁc, USA)
with Xcalibular station was used in the study. GC separation was
accomplished on HP-5MS column (30 m 0.25 mm i.d., 0.25 μm
particle size). The inlet temperature was set at 210 1C. The oven
temperature program was started at an initial temperature of 80 1C,
lasting for 1.0 min, then increased to 145 1C at 30 1C/min and
retained for 3.0 min. Samples were injected in the split mode
(1/10), using helium as carrier gas (99.9%, 1 mL/min). In the MS
system, both the ion source temperature and inlet temperature were
280 1C. Electron impact ionization (EI) mode was used with
nominal electron energy (70 eV). Selected ion monitor (SIM, m/z)
of NB, camphor and IS was 95, 95 and 128, respectively.
Processing data were acquired from 3.00 to 6.18 min.
2.3. Preparation of standard and quality control (QC) samples
The stock solutions of NB (100 μg/mL), camphor (100 μg/mL)
and IS (100 μg/mL) were prepared in hexane. A series of working
solutions were obtained by diluting stock solutions with hexane.
The IS working solution (100 ng/mL) was prepared by diluting
stock solution with hexane. All solutions were stored at 4 1C and
shielded from light.
Appropriate amounts of NB and camphor working solutions
were added to 100 μL blank plasma to yield effective concentra-
tion in plasma. Effective concentrations in plasma samples were
15, 30, 150, 300, 1500, 3000 and 4000 ng/mL for NB, while 30,
60, 150, 300, 1500, 3000 and 4000 ng/mL for camphor. The QC
samples used in the validation and during the pharmacokinetic
study were prepared in the same way as the calibration standard.
The three QC concentrations of NB (camphor) were 30 (60), 300
(300) and 3000 (3000) ng/mL.
2.4. Sample preparation
20 μL IS (100 ng/mL) working solution and 130 μL hexane were
added to an aliquot of 100 μL rat plasma sample; the mixture wasthen vortex-mixed for 3 min. Then 100 μL supernatant was
transferred to glass conical inserts after centrifugation for 10 min
at 15,000 rpm (4 1C) and placed into 2 mL brown autosampler
vials (22 1C) with screwtop caps and PTFE septa. One microliter
of supernatant was injected into the GC–MS system.
2.5. Method validation
2.5.1. Selectivity
The selectivity of the method was investigated by comparing
chromatograms of blank plasma, blank plasma sample spiked with
standard at lower limit of quantiﬁcation (LLOQ) and plasma
sample at 0.25 h after oral administration of NB (90 mg/kg).
2.5.2. Linearity and LLOQ
The calibration curve consisted of six concentration levels. Each of
these samples was prepared and assayed in triplicate on three
separate days. The calibration curve was obtained by plotting the
peak area ratio (Y) of the analyte to IS versus the nominal
concentration (X) of either NB or camphor. These curves were
described as y¼aþbx (1/x2 weighted). LLOQ was deﬁned as the
lowest concentration whose precision (expressed as relative
standard deviation, RSD) and accuracy (expressed as relative
error, RE) were both r20%.
2.5.3. Accuracy and precision
The accuracy and precision of the method were assessed by
analyzing three QC levels samples each in six replicates on three
consecutive days. The inter- and intra-day precision is expressed
as the relative standard deviation (RSD). Accuracy is deﬁned as
the relative error (RE) and is calculated using the formula RE (%)¼
[(measured value theoretical value)]/theoretical value 100%.
Both accuracy (RE) and precision (RSD) were expected to be
within 715% as being acceptable.
2.5.4. Extraction recovery
Extraction recoveries of NB and camphor were assessed by
comparing the peak responses from QC samples to those from
post-extracted samples. QC samples were prepared according to
previous descriptions; post-extracted samples were prepared as
follows: blank plasma samples were extracted and then spiked
with standard solutions to yield corresponding equivalent concen-
trations. Recoveries were tested at three QC levels each in ﬁve
replicates and should be stable.
2.5.5. Stability
Samples at two concentrations levels (150 ng/mL and 3000 ng/mL
for NB and camphor) were used in the stability test containing pre-
treatment, post-treatment, three cycles of freeze–thaw, and long-term
stabilities of the analytes. Pre-treatment stability was assessed by
leaving samples at room temperature for 3 h before extraction.
For post-treatment assessment, all processed samples were placed
into autosampler (22 1C) for 10 h before injection. Freeze–thaw cycle
plasma stability test was carried out via repeatedly freezing–thawing
samples for three cycles before extraction. Long-term stability was
evaluated by storing samples at 20 1C and 80 1C for 24 h before
thawing and extraction.
2.5.6. Pharmacokinetic application of the GC–MS method
The study was approved by the Animal Ethics Committee of
Guangdong Province. Six male Wistar rats weighing 200720 g
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Yat-sen University (Guangzhou, China, Certiﬁcate no. SCXK
20110029). The rats were housed in steel cages at 22–26 1C and
50–60% humidity; all animals were allowed free access to tap
water but food was withdrawn overnight before the experiment.
Rats were administered with a single oral dose (90 mg/kg) of NB
suspension in 0.8% carboxymethyl cellulose sodium (correspond-
ing to 0.9 g, the dose a human takes per day). Serial blood samples
(0.25 mL) were obtained from the orbital veins at 0, 0.083, 0.167,
0.25, 0.333, 0.5, 0.75, 1, 1.5, 2.5, 4 and 6 h after dosing and
immediately centrifuged for 5 min at 15,000 rpm (4 1C) to obtain
plasma samples.
The pharmacokinetic parameters were obtained by using
Winnonlin 5.0.1 software. Cmax (peak plasma concentration), tmax
(the time to reach peak plasma concentration), and β (elimination
rate constant) were determined by linear regression analysis of the
logarithmic transformation of the last four data points of the curve.
t1/2β (halftime of elimination), T1/2 (0.693/k), and AUC0–t [the area
under the plasma concentration–time curve up to the last time (t)]
were determined using the trapezoidal rule. AUC0–1 (the area
under the concentration–time curve) was calculated by adding the
value of Ct/k to AUC0–t. MRT0–1 (mean residence time) wasFig. 2 The product ion mass spectra, chemical structures monitoredequal to the value of AUMC/AUC; AUC0–1 ratio was equal to the
value of aAUC0–1/
bAUC0–1, a: the metabolite camphor and b: the
parent drug borneol.3. Results and discussions
3.1. Optimization of GC–MS conditions
We referred to the gradient temperature program in the study of
Huang et al. [14], but changed the last retaining time from 2 min to
3 min. The application of the modiﬁed gradient temperature
program ensured that the main peaks could be detected in only
6.18 min with excellent resolution. Fig. 2 shows the mass spectra
of NB, camphor and IS. According to the relative abundance of
each fragment ion in mass spectra, the fragment ion m/z 95 was
used for the analysis of NB and camphor, and m/z 128 for the
analysis of IS. The SIM mode in the study was selected to avoid
the analytical interference of endogenous substance and achieve
required selectivity.transitions of borneol (A) and camphor (B), and naphthalene (C).
Fig. 3 Representitive SIM chromatograms for NB and camphor in rat plasma: (A) a blank plasma; (B) a blank plasma spiked with NB (30 ng/mL) and
camphor (60 ng/mL) at LLOQ level; and (C) a plasma sample at 0.25 h after oral administration of NB (90 mg/kg).
Table 1 Accuracy, precision (3 days, 6 replicates per day) and recovery (n¼5) for NB and camphor in rat plasma.
Compound Nominal concentration (ng/mL) Precision Accuracy (RE, %) Recovery
Intra-day Inter-day Mean7SD (%) RSD (%)
RSD (%) RSD (%)
NB 30 6.7 13.3 6.7 101.576.9 6.8
300 4.5 14.0 8.5 99.779.3 9.3
3000 8.6 11.5 3.2 101.676.0 5.9
Camphor 60 6.7 12.8 0.7 91.678.3 10.0
300 8.2 14.1 7.7 102.479.4 10.0
3000 5.8 13.7 7.8 102.378.1 7.9
IS 100 83.774.7 5.6
RSD: relative standard deviation; RE: relative error.
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Table 2 Stability for natural borneol (NB) and camphor in rat plasma (n¼3).
Conditions Nominal concentration (ng/mL) Calculated concentration (ng/mL) RE (%)
NB Camphor NB Camphor NB Camphor
Three freeze–thaw cycles 150 150 85.472.0 75.175.0 43.1 49.9
3000 3000 1470765 18517130 51.0 38.3
Post-freezing (20 1C) for 24 h 150 150 100.073.4 119.178.8 33.4 20.6
3000 3000 22027292 23787336 26.6 20.7
Post-freezing (80 1C) for 24 h 150 150 101.378.4 94.477.9 32.4 37.1
3000 3000 21447179 20827235 28.5 30.6
Benchtop for 3 h (room temperature) 150 150 159.2713.4 15476.3 6.1 3.0
3000 3000 2794733 2722754 6.9 9.3
Post-preparative (20 1C) for 24 h 150 150 144.574.3 142.276.7 3.7 5.2
3000 3000 2880746 2883756 4.0 3.9
RE: relative error.
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Fig. 3 shows the typical chromatograms of blank plasma (A),
plasma sample spiked with NB, camphor and IS (B), and plasma
sample from a rat after oral administration of NB (90 mg/kg) (C).
The retention time of camphor, NB and IS was 4.79, 5.04 and
5.33 min, respectively. Blank rat plasma yielded relative clean
chromatograms without interfering peaks both to the analytes
and IS.
Good linearity was obtained within the range of 15–4000 ng/mL
for NB (r¼0.9911) and 30–4000 ng/mL for camphor (r¼0.9937).
The LLOQ for NB and camphor was 15 ng/mL with RSD 15.2%
and 30 ng/mL with RSD 14.3%, respectively.3.3. Accuracy and precision
The results of accuracy and precision are shown in Table 1. The
intra-day and inter-day precisions (RSD) were less than 14.1% for
each QC level of NB and camphor. The accuracy (RE) was within
78.5% of the target values. These results indicated that it was a
precise and accurate method.3.4. Recovery
As shown in Table 1, the overall recovery efﬁciency for NB was
94.0% at 30 ng/mL, 93.9% at 300 ng/mL and 91.4% at 3000 ng/mL;
the recovery for camphor was 89.5% at 60 ng/mL, 91.0% at 300
ng/mL and 93.0% at 3000 ng/mL; the recovery for IS was 83.7%.
The recovery results indicated that hexane was a feasible and
appropriate medium for NB, camphor and IS extraction.3.5. Stability
The stability results (Table 2) indicated that samples were stable
on the bench at room temperature for 3 h and at 22 1C environ-
ment for 10 h after processing, but not stable in freeze–thaw test
and post-freezing stability test in 20 1C and 80 1C environment.
It suggested that plasma samples should be processed and
determined immediately after obtaining, not be long-term stored orundergo repeated freeze–thaw cycle; processed samples could be
placed into autosampler (22 1C) for less than 10 h for batch analysis.3.6. Application of the developed GC–MS method
According to the provision for NB in the Chinese Pharmacopoeia
(Ch.P) [9], the recommended dosage for adults is 0.3–0.9 g. This
range of dosage converted for rats is 30–90 mg/kg. We employed
90 mg/kg as dosage administration to rats in consideration of the
simultaneous determination for NB and its metabolite camphor.
Previously, gas chromatography (GC) with the ﬂame ionization
detection (FID) method was applied to detect NB and menthol in
the biomatrix study of Xu et al. [10]. Huang et al. [14] also
developed a GC–MS method to investigate NB distribution in
mice which referred to the study on the meridian tropism of NB. Li
et al. [15] determined the concentration of NB in the brain with a
GC–MS method. In this study, we referred to the above papers and
developed a GC–MS method to measure the concentration of NB
and its metabolite in rat plasma and it has been successfully
applied to the pharmacokinetic study of NB and its metabolite.
The plasma proﬁles of NB and its metabolite, camphor, after oral
administration (90 mg/kg) to rats are shown in Fig. 4. For NB,
measured concentration ranged from a maximum concentration of
311.35 ng/mL at 0.27 h to a lower concentration of 40.00 ng/mL at
1.5 h and remained stable from 1.5 h to 6 h, which was similar to other
previous reports (absorbed rapidly and eliminated rapidly). For
camphor, measured concentration reached a maximum level of
150.61 ng/mL at 0.28 h, and the concentration of camphor was below
the limit of quantitation after 1.5 h. It indicated that NB was absorbed
and metabolized to camphor; meanwhile, camphor could be absorbed
rapidly. The concentration of two compounds reached a maximum
level at about the same time. The disappearance of the parent drug NB
from the plasma was slower with longer MRT0–1 than that of the
metabolite, camphor. The AUC0–1 ratio of camphor to NB was 0.32,
which indicated that NB was metabolized to camphor to a large extent.
In view of high toxicity brought by small-dose exposure to camphor,
preparations containing NB should not be applied in children and
pregnant women without caution, because infants and fetuses lack the
enzymes to hydroxylate and conjugate camphor which could result in
Fig. 4 The mean plasma concentration–time proﬁles of NB and
camphor after oral administration of NB (90 mg/kg) in Wistar rats
(mean7SD, n¼6).
Table 3 Pharmacokinetic parameters of NB and camphor
after oral administration of NB (90 mg/kg) in Wistar rats
(mean7SD, n¼6).
Parameter NB Camphor
Cmax (ng/mL) 311.357192.09 150.61717.50
tmax (h) 0.2770.08 0.2870.05
β (h1) 0.7670.61 0.7270.12
t1/2β (h) 1.3370.78 1.0170.09
AUC0–t (h ng/mL) 519.17775.95 125.16736.11
AUC0–1 (h ng/mL) 568.97782.35 192.16737.91
MRT0–1 (h) 5.5070.85 1.5570.38
AUC0–1 ratio 0.3270.07
SD: standard deviation.
X.-M. Sun et al.350camphor accumulation and cause neuronal damage in the cortex and
basal ganglia. Pharmacokinetic parameters are summarized in Table 3.4. Conclusions
A sensitive and selective GC–MS method for the simultaneous
determination of NB and camphor in rat plasma was developed
and validated. The proposed method showed appropriate accuracy
and precision and was successfully applied for analysis of NB and
camphor in rat plasma after oral administration of NB, whichindicated that the method is suitable for pharmacokinetic study of
NB and camphor.
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